Sep 14, 2022

Public workspaceMidbrain organoid generation from mfNPC

  • Rachel Bates1
  • 1UCL
Icon indicating open access to content
QR code linking to this content
Protocol CitationRachel Bates 2022. Midbrain organoid generation from mfNPC. protocols.io https://dx.doi.org/10.17504/protocols.io.6qpvr4x1pgmk/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: September 07, 2022
Last Modified: May 31, 2024
Protocol Integer ID: 69682
Keywords: ASAPCRN
Funders Acknowledgement:
ASAP
Grant ID: ASAP2022
Abstract
This protocol describes our method for the differentiation of human floor plate neural progenitor cells into human midbrain-like organoids (hMLOs). This protocol has been developed using a combination of several published protocols.

Adapted from
CITATION
Jo J, Xiao Y, Sun AX, Cukuroglu E, Tran HD, Göke J, Tan ZY, Saw TY, Tan CP, Lokman H, Lee Y, Kim D, Ko HS, Kim SO, Park JH, Cho NJ, Hyde TM, Kleinman JE, Shin JH, Weinberger DR, Tan EK, Je HS, Ng HH (2016). Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.. Cell stem cell.

CITATION
Mohamed NV, Sirois J, Ramamurthy J, Mathur M, Lépine P, Deneault E, Maussion G, Nicouleau M, Chen CX, Abdian N, Soubannier V, Cai E, Nami H, Thomas RA, Wen D, Tabatabaei M, Beitel LK, Singh Dolt K, Karamchandani J, Stratton JA, Kunath T, Fon EA, Durcan TM (2021). Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy.. Brain communications.

Protocol materials
ReagentStemolecule LDN-193189Stemgent - Bio-connectCatalog #04-0074
Step 1.1
ReagentL-Ascorbic acidMerck MilliporeSigma (Sigma-Aldrich)Catalog #A4403
In 5 steps
ReagentCHIR99021R&D SystemsCatalog #4423
In 3 steps
ReagentNeurobasal Plus MediumGibco, ThermoFisherCatalog #A3582901
In 5 steps
ReagentN-2 max supplementR&D SystemsCatalog #AR009
In 5 steps
ReagentDb-cAMP (dibutyryl-cyclic AMP)Merck MilliporeSigma (Sigma-Aldrich)Catalog #D0627
Step 15.1
ReagentCultrex Reduced Growth Factor Basement Membrane ExtractR&D SystemsCatalog #343301001
In 2 steps
ReagentUltra-low attachment 6-well plateCorningCatalog #CLS3471
Step 12
ReagentSB431542Cell Signaling TechnologyCatalog #14775
Step 1.1
ReagentMEM, NEAA, no glutamineThermo FisherCatalog #10370021
In 5 steps
Reagentrecombinant human SHH proteinQkine
In 4 steps
ReagentN21-MAX Media Supplement (50X)R&D SystemsCatalog #AR008
In 5 steps
ReagentInsulinMerck MilliporeSigma (Sigma-Aldrich)Catalog #I2643-25MG
Step 10.1
ReagentFGF8Novus BiologicalsCatalog #423-F8-025
In 4 steps
ReagentSAG 1 mg STEMCELL Technologies Inc.Catalog #73412
In 2 steps
ReagentGlutamax (100x)Gibco - Thermo FischerCatalog #35050-061
In 5 steps
ReagentLaminin from Engelbreth-Holm-Swarm murine sarcoma basement membraneMerck MilliporeSigma (Sigma-Aldrich)Catalog #L2020
Step 10.1
ReagentBDNFQkineCatalog #QK050
Step 15.1
ReagentGDNFQkineCatalog #QK051
Step 15.1
ReagentDMEM/F-12Thermo FisherCatalog #11320033
In 3 steps
Day 0
Day 0
Human floor plate neuronal progenitor cells (mfNPC) were derived using Smits 2019 protocol. They were maintained for a minimum of 5 passages before being used to generate organoids in maintenance medium.


CITATION
Fedele S, Collo G, Behr K, Bischofberger J, Müller S, Kunath T, Christensen K, Gündner AL, Graf M, Jagasia R, Taylor V (2017). Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential.. Scientific reports.

CITATION
Smits LM, Reinhardt L, Reinhardt P, Glatza M, Monzel AS, Stanslowsky N, Rosato-Siri MD, Zanon A, Antony PM, Bellmann J, Nicklas SM, Hemmer K, Qing X, Berger E, Kalmbach N, Ehrlich M, Bolognin S, Hicks AA, Wegner F, Sterneckert JL, Schwamborn JC (2019). Modeling Parkinson's disease in midbrain-like organoids.. NPJ Parkinson's disease.

mfNPC maintenance medium

Concentration50 % volume ReagentDMEM/F-12Sigma AldrichCatalog #11320033
Concentration50 % volume ReagentNeurobasal Plus MediumSigma AldrichCatalog #A3582901
1:50 ReagentN21-MAX Media Supplement (50X)Sigma AldrichCatalog #AR008
1:100 ReagentN-2 max supplementSigma AldrichCatalog #AR009
Concentration1 % volume ReagentGlutamax (100x)Sigma AldrichCatalog #35050-061
Concentration1 % volume ReagentMEM, NEAA, no glutamineSigma AldrichCatalog #10370021
Concentration10 micromolar (µM) ReagentSB431542Sigma AldrichCatalog #14775
Concentration0.5 micromolar (µM) ReagentSAG 1 mg Sigma AldrichCatalog #73412
Concentration250 millimolar (mM) ReagentStemolecule LDN-193189Sigma AldrichCatalog #04-0074
Concentration200 micromolar (µM) ReagentL-Ascorbic acidSigma AldrichCatalog #A4403
Concentration3 micromolar (µM) ReagentCHIR99021Sigma AldrichCatalog #4423



mfNPCs were detached using accutase at Temperature37 °C for Duration00:03:00 .

3m
Re-suspend cells in d0 induction medium and plate 9,000 cell/well in ultra-low attachment U-bottomed 96 well plates.
Note
BIOFLOAT plate from Facellitate work best for us compared to Corning or Nunc at producing uniform EBs.

Day 2
Day 2
Change the medium to mfNPC medium supplemented with Concentration0.0001 mg/mL ReagentFGF8Sigma AldrichCatalog #423-F8-025 Concentration0.0001 mg/mL Reagentrecombinant human SHH proteinSigma Aldrich being careful not to touch the organoid.



Day 4
Day 4
Change the medium to patterning I medium adding Amount300 µL per well.

patterning I medium

Concentration50 % volume ReagentDMEM/F-12Sigma AldrichCatalog #11320033
Concentration50 % volume ReagentNeurobasal Plus MediumSigma AldrichCatalog #A3582901
1:50 ReagentN21-MAX Media Supplement (50X)Sigma AldrichCatalog #AR008
1:100 ReagentN-2 max supplementSigma AldrichCatalog #AR009
Concentration1 % volume ReagentGlutamax (100x)Sigma AldrichCatalog #35050-061
Concentration1 % volume ReagentMEM, NEAA, no glutamineSigma AldrichCatalog #10370021
Concentration0.5 micromolar (µM) ReagentSAG 1 mg Sigma AldrichCatalog #73412
Concentration200 micromolar (µM) ReagentL-Ascorbic acidSigma AldrichCatalog #A4403
Concentration3 micromolar (µM) ReagentCHIR99021Sigma AldrichCatalog #4423
Concentration0.0001 mg/mL ReagentFGF8Sigma AldrichCatalog #423-F8-025
Concentration0.0001 mg/mL Reagentrecombinant human SHH proteinSigma Aldrich
Day 6
Day 6
Change medium to patterning II medium with reduced CHIRR adding Amount300 µL per well.

Patterning II medium

Concentration50 % volume ReagentDMEM/F-12Sigma AldrichCatalog #11320033
Concentration50 % volume ReagentNeurobasal Plus MediumSigma AldrichCatalog #A3582901
1:50 ReagentN21-MAX Media Supplement (50X)Sigma AldrichCatalog #AR008
1:100 ReagentN-2 max supplementSigma AldrichCatalog #AR009
Concentration1 % volume ReagentGlutamax (100x)Sigma AldrichCatalog #35050-061
Concentration1 % volume ReagentMEM, NEAA, no glutamineSigma AldrichCatalog #10370021
Concentration200 micromolar (µM) ReagentL-Ascorbic acidSigma AldrichCatalog #A4403
Concentration0.7 micromolar (µM) ReagentCHIR99021Sigma AldrichCatalog #4423
Concentration0.0001 mg/mL ReagentFGF8Sigma AldrichCatalog #423-F8-025
Concentration0.0001 mg/mL Reagentrecombinant human SHH proteinSigma Aldrich
Thaw ReagentCultrex Reduced Growth Factor Basement Membrane ExtractSigma AldrichCatalog #343301001 DurationOvernight at Temperature4 °C ready for next day.

Day 8
Day 8
30m
30m
Carefully remove as much medium as possible from each well being careful not to touch the organoid.
Add Amount15 µL ofReagentCultrex Reduced Growth Factor Basement Membrane ExtractSigma AldrichCatalog #343301001 to each well and return to Temperature37 °C incubator for Duration00:30:00 .

30m
Carefully add Amount300 µL of tissue induction medium to each well.
Note
Some organoids may float others with remain attached to plate, this does not affect the organoid.


Tissue induction medium


Concentration100 % volume ReagentNeurobasal Plus MediumSigma AldrichCatalog #A3582901
1:50 ReagentN21-MAX Media Supplement (50X)Sigma AldrichCatalog #AR008
1:100 ReagentN-2 max supplementSigma AldrichCatalog #AR009
Concentration1 % volume ReagentGlutamax (100x)Sigma AldrichCatalog #35050-061
Concentration1 % volume ReagentMEM, NEAA, no glutamineSigma AldrichCatalog #10370021
Concentration200 micromolar (µM) ReagentL-Ascorbic acidSigma AldrichCatalog #A4403
Concentration0.0001 mg/mL ReagentFGF8Sigma AldrichCatalog #423-F8-025
Concentration0.0001 mg/mL Reagentrecombinant human SHH proteinSigma Aldrich
Concentration0.00025 mg/mL ReagentLaminin from Engelbreth-Holm-Swarm murine sarcoma basement membraneSigma AldrichCatalog #L2020
Concentration0.025 mg/mL ReagentInsulinSigma AldrichCatalog #I2643-25MG

Day 9
Day 9
30m
30m
Using sterilised scissors or a scalpel blade cut a pasteur pipette at the widest point.
Note
this will provide a sufficient bore to pick up the embedded organoid without damaging the cultrex.

Either add Amount2 mL of Tissue induction medium to ReagentUltra-low attachment 6-well plateSigma AldrichCatalog #CLS3471 or add Amount500 µL to Ultra-low attachment 48 well plate.

using the cut pasteur pipette carefully pick up each organoid and move to new plate. For 6 well plate add up to 6 organoids per well or 1 per well in the 48-well plate.
Incubate plates at Temperature37 °C on a orbital shaker set to Shaker70 rpm .

Day 10
Day 10
Change medium to Differentiation medium.
Differentiation medium

Concentration100 % volume ReagentNeurobasal Plus MediumSigma AldrichCatalog #A3582901
1:50 ReagentN21-MAX Media Supplement (50X)Sigma AldrichCatalog #AR008
1:100 ReagentN-2 max supplementSigma AldrichCatalog #AR009
Concentration1 % volume ReagentGlutamax (100x)Sigma AldrichCatalog #35050-061
Concentration1 % volume ReagentMEM, NEAA, no glutamineSigma AldrichCatalog #10370021
Concentration200 micromolar (µM) ReagentL-Ascorbic acidSigma AldrichCatalog #A4403
Concentration125 micromolar (µM) ReagentDb-cAMP (dibutyryl-cyclic AMP)Sigma AldrichCatalog #D0627
10ng/mLReagentBDNFSigma AldrichCatalog #QK050
10ng/mLReagentGDNFSigma AldrichCatalog #QK051

After day 10 perform a 75% medium change every 2-3 days.

Citations
Jo J, Xiao Y, Sun AX, Cukuroglu E, Tran HD, Göke J, Tan ZY, Saw TY, Tan CP, Lokman H, Lee Y, Kim D, Ko HS, Kim SO, Park JH, Cho NJ, Hyde TM, Kleinman JE, Shin JH, Weinberger DR, Tan EK, Je HS, Ng HH. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.
https://doi.org/10.1016/j.stem.2016.07.005
Mohamed NV, Sirois J, Ramamurthy J, Mathur M, Lépine P, Deneault E, Maussion G, Nicouleau M, Chen CX, Abdian N, Soubannier V, Cai E, Nami H, Thomas RA, Wen D, Tabatabaei M, Beitel LK, Singh Dolt K, Karamchandani J, Stratton JA, Kunath T, Fon EA, Durcan TM. Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy.
https://doi.org/10.1093/braincomms/fcab223
Step 1
Fedele S, Collo G, Behr K, Bischofberger J, Müller S, Kunath T, Christensen K, Gündner AL, Graf M, Jagasia R, Taylor V. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential.
https://doi.org/10.1038/s41598-017-05633-1
Step 1
Smits LM, Reinhardt L, Reinhardt P, Glatza M, Monzel AS, Stanslowsky N, Rosato-Siri MD, Zanon A, Antony PM, Bellmann J, Nicklas SM, Hemmer K, Qing X, Berger E, Kalmbach N, Ehrlich M, Bolognin S, Hicks AA, Wegner F, Sterneckert JL, Schwamborn JC. Modeling Parkinson's disease in midbrain-like organoids.
https://doi.org/10.1038/s41531-019-0078-4